Nymox Announces New Appointment of Russell Thomson Ph.D. as Nymox Vice President of Quality and Regulatory Affairs
06 févr. 2020 09h30 HE
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., Feb. 06, 2020 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to announce the new appointment of Russell I. Thomson PhD, FRSC to the position...
Nymox Provides Update on Current Corporate Activities and Milestones
28 janv. 2020 09h30 HE
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., Jan. 28, 2020 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to provide a current January 2020 update on several important corporate...
Nymox Announces New Peer Review Article on Fexapotide Pharmaco-Ablation Experimental Studies Published in Research and Reports in Urology
06 janv. 2020 11h00 HE
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to report a new peer review research report has been published on experimental...
Nymox Reports on Newly Issued Patents and Corporate Developments
21 oct. 2019 09h30 HE
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., Oct. 21, 2019 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to report very positive fundamental news, that the Company has received several...
Nymox End of Q2 New Investor Presentation on Website
25 juin 2019 11h45 HE
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., June 25, 2019 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to provide an up-to-date investor communication presentation posted on the Nymox...
Nymox Reports Pre-NDA CMC Meeting with the FDA
16 avr. 2019 12h46 HE
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., April 16, 2019 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced that it has held its pre-New Drug Application (NDA) Chemistry...
Nymox Teleconference Monday, March 25 10:00 a.m. EDT
21 mars 2019 13h45 HE
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., March 21, 2019 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) Nymox will hold a teleconference for shareholders on Monday, March 25 at 10:00 a.m....
Nymox Announces Appointment of Mark Staples PhD as Vice President of Chemistry, Manufacturing and Controls (CMC)
19 mars 2019 09h45 HE
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., March 19, 2019 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce that Mark Staples PhD has joined Nymox as Vice President for...
Nymox Announces Appointment of Russell Thomson Ph.D. as Director of Quality and EU Qualified Person for Company's Manufacturing Operations
13 mars 2019 09h30 HE
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., March 13, 2019 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to announce the new appointment of Russell I. Thomson PhD, FRSC, as the...
Nymox to Host Investor Teleconference
11 mars 2019 11h53 HE
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., March 11, 2019 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) will hold a teleconference for shareholders on March 25, 2019. Management will discuss the...